Polisi dan Garis Panduan Perkhidmatan Farmasi Farmakokinetik Klinikal Edisi Kedua 2022

The update of this policy and guideline encompasses the following:

1. Revocation of the pharmacy-based sample analysis component following the transition of sample analysis by Pathology Department.
2. This policy and guideline are applicable to health clinics offering Clinical Pharmacokinetics Services.
3. Scope of work, interpretation and recommendation for Therapeutic Drug Monitoring (TDM) analysis, as well as training requirements for pharmacists in Clinical Pharmacokinetics Services.
4. Additional flowchart for the health clinic's workflow process.